Braverman L E, Foster A E, Ingbar S H
J Clin Invest. 1968 Jun;47(6):1349-57. doi: 10.1172/JCI105827.
Multiple indices of thyroid hormone binding have been studied in sera obtained from patients with thyrotoxic Graves' disease, before and after treatment, and in sera from a group of carefully matched normal controls. Specimens from patients with thyrotoxicosis displayed a decrease in the thyroxine (T(4))-binding capacities of T(4)-binding globulin (TBG) and T(4)-binding prealbumin (TBPA), an increase in serum protein-bound iodine (PBI), and an increase in both the proportion and absolute concentration of free T(4). In addition, a smaller than normal proportion of (131)I-labeled T(3) was associated with TBG during filter paper electrophoresis. After treatment of thyroxicosis, the only residual abnormality detected was a very slight persistent decrease in the T(4)-binding capacity of TBPA, which did not appear to influence the overall thyroid hormone-plasma protein interaction significantly, regardless of whether this was assessed under basal conditions or after enrichment of specimens with stable T(4). It is concluded that the persistent abnormalities in the peripheral metabolism of T(4), previously reported to occur in some patients with treated Graves' disease, probably do not stem from residual abnormalities in the transport of T(4) in the plasma but must arise from abnormalities in T(4) accumulation or metabolism within the tissues themselves.
对甲状腺功能亢进型格雷夫斯病患者治疗前后以及一组经过仔细匹配的正常对照者的血清,研究了多种甲状腺激素结合指标。甲状腺毒症患者的标本显示,甲状腺素结合球蛋白(TBG)和甲状腺素结合前白蛋白(TBPA)的甲状腺素(T4)结合能力降低,血清蛋白结合碘(PBI)增加,游离T4的比例和绝对浓度均增加。此外,在滤纸电泳期间,与TBG结合的(131)I标记T3的比例低于正常。甲状腺毒症治疗后,检测到的唯一残留异常是TBPA的T4结合能力持续非常轻微地降低,无论这是在基础条件下评估还是在用稳定T4富集标本后评估,这似乎都不会对甲状腺激素与血浆蛋白的总体相互作用产生显著影响。得出的结论是,先前报道的一些接受治疗的格雷夫斯病患者中出现的T4外周代谢持续异常,可能并非源于血浆中T4转运的残留异常,而是一定源于组织自身内T4积累或代谢的异常。